Literature DB >> 2487781

Lack of specificity of Chlamydiazyme for detection of vaginal chlamydial infection in prepubertal girls.

K Porder1, N Sanchez, P M Roblin, M McHugh, M R Hammerschlag.   

Abstract

A 1-year prospective study was undertaken of 65 prepubertal girls referred for evaluation of sexual abuse or vulvovaginitis to compare Chlamydiazyme, an enzyme immunoassay (EIA), with culture for the detection of Chlamydia trachomatis i in vaginal specimens. Five (8%) of 65 patients were initially EIA-positive. On repeat sampling without intervening antibiotic treatment, 4 girls who were initially positive became negative and 1 remained persistently positive. Chlamydial cultures were negative in all patients. The patient with the persistently positive EIA also had Group A streptococcal vaginitis. We were able to demonstrate that some strains of Group A Streptococcus can cause a positive reaction with the EIA. Cross-reactions with other bacterial species are also known to occur. We therefore conclude that Chlamydiazyme is not specific for the detection of chlamydial infection in the vagina of prepubertal girls and, for medicolegal reasons, should not be used for evaluation of sexual abuse.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487781     DOI: 10.1097/00006454-198906000-00006

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  Value of confirmation of Chlamydiazyme enzyme immunoassay results in the detection of Chlamydia trachomatis.

Authors:  H Hallander; P Jonsson; B Gästrin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

2.  Effect of endocervical specimen quality on detection of Chlamydia trachomatis and on the incidence of false-positive results with the Chlamydiazyme method.

Authors:  J A Kellogg; J W Seiple; C L Murray; J S Levisky
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 3.  Medical and legal implications of testing for sexually transmitted infections in children.

Authors:  Margaret R Hammerschlag; Christina D Guillén
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

4.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

5.  False-positive Chlamydiazyme results during urine sediment analysis due to bacterial urinary tract infections.

Authors:  J Demaio; R S Boyd; R Rensi; A Clark
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

Review 6.  Sexually transmitted diseases in sexually abused children: medical and legal implications.

Authors:  M R Hammerschlag
Journal:  Sex Transm Infect       Date:  1998-06       Impact factor: 3.519

7.  Evaluation of chlamydiazyme enzyme immunoassay for detection of Chlamydia trachomatis in urine specimens from men.

Authors:  J M Ehret; J C Leszcynski; J M Douglas; S L Genova; M A Chernesky; J Moncada; J Schachter
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.